Tag: Viral therapy

Jeffrey Smith

Associate Professor & Director, Carleton Mass Spectrometry Centre (CMSC), Department of Chemistry, Carleton University Associate Professor, Institute of Biochemistry, Carleton University   Full Biography   Cancers of Interest Blood Bone Breast Colorectal Liver Ovarian Pancreatic Prostate Skin Soft Tissue Sarcoma   Projects at BioCanRx Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral… Read more »

Brad Nelson

Scientific Co-Director, BC Cancer Immunotherapy Program (Deeley Research Centre) Professor of Biochemistry/Microbiology, University of Victoria Professor of Medical Genetics, University of British Columbia   Full Biography   Projects at BioCanRx Enabling a Phase I/II Multicenter Clinical Trial of a Novel Single Domain (sd)CD-22-specific Camelid-derived Chimeric Antigen Receptor (CAR) T-cell Therapy   Interrogation of Biomarkers in… Read more »

Karen Mossman

Professor, Pathology and Molecular Medicine, McMaster University Vice President, Research, McMaster University   Full Biography   Cancers of Interest Breast Cancer   Projects at BioCanRx In vivo genome-wide CRISPR/Cas9 screen to identify genes that limit curative checkpoint blockade immunotherapy in triple negative breast cancer   Recent Articles I study viruses: How our team isolated the… Read more »

Jason Moffat

Professor & Principal Investigator, Department of Molecular Genetics, University of Toronto Canada Research Chair in Functional Genomics of Cancer   Full Biography   Cancers of Interest Skin   Research and clinical approaches Our research is concentrated in three areas:   Identification of genetic interactions and differential gene essentiality in mammalian cancer cell lines Cancer cell… Read more »

Brian Lichty

PhD, Associate Professor, Pathology and Molecular Medicine, McMaster   Full Biography   Cancers of Interest Breast Cervical Gynecological Lung Prostate Skin   Projects at BioCanRx Development of a Virally Programmed Exosome-based Cancer Vaccine Platform   COMBINING ONCOLYTIC VACCINE THERAPY WITH ADOPTIVE CELL THERAPY TO TARGET CANCERS EXPRESSING MAGE-A3   A Phase 1/1b, Multicenter, Open-label Trial… Read more »

Natasha Kekre

Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute Hematologist, Blood and Marrow Transplant Program, The Ottawa Hospital Associate Professor, University of Ottawa   Full Biography   Cancers of Interest Blood   Research Interests Hematopoietic Stem Cell Transplantation Oncolytic Viruses Cellular immunotherapy (CAR-T cells) Leukemia Lymphoma Clinical Epidemiology   Projects at BioCanRx Clinical Trial Enabling… Read more »

Carolina Ilkow

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Associate Professor, University of Ottawa   Full Biography   Cancers of Interest Breast Cervical Colorectal Gynecologic Head and Neck Ovarian Pancreatic   Projects at BioCanRx Development of a Virally Programmed Exosome-based Cancer Vaccine Platform

Glenwood Goss

FCPSA, FRCPC Professor of Medicine, University of Ottawa, Division of Medical Oncology Chair, Thoracic Oncology Site Committee Director of Clinical and Translational Research, Ottawa Hospital Cancer Centre   Full Biography   Cancers of Interest Lung   Projects at BioCanRx Interrogation of Biomarkers in Patient Samples from a Phase Ib Trial of the Immune Checkpoint Inhibitor,… Read more »

Kevin Hay

Clinician Scientist & Hematologist, The Leukemia/Bone Marrow Transplant Program of BC, BC Cancer and Vancouver General Hospital Medical Director, CFIL, Immunotherapy Program of BC Scientist, Terry Fox Laboratory, BC Cancer Research Institute Assistant Professor. Department of Medicine, University of British Columbia   Full Biography   Cancers of Interest Blood   Research and clinical approaches Bioinformatics,… Read more »

David Evans

Professor and Vice-Dean (Research), Department of Medical Microbiology & Immunology, University of Alberta   Full Biography   Cancers of Interest Bladder Breast   Projects at BioCanRx Oncolytic vaccinia virus for bladder cancer treatment: preparation for a phase I/II study   Recent Articles BioCanRx Summer Students Tell All   Introducing the winners of BioCanRx’s 2018 Summer… Read more »